Benzinga - Thu, 06 May 2021 04:16:53 -0400
Benzinga - Tue, 13 Apr 2021 05:18:31 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
Benzinga - Mon, 12 Apr 2021 05:10:38 -0400
Benzinga - Fri, 09 Apr 2021 12:02:10 -0400
Benzinga - Fri, 09 Apr 2021 08:17:21 -0400
Benzinga - Wed, 07 Apr 2021 10:06:42 -0400
load more
Sector: Health Care.Industry: Biotechnology
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. Its product pipeline includes Cirmtuzumab, TK216, and ROR1 CAR-T.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.100-0.120 -0.0200
REV1.110M748.000K-362.000K
Q4 2020Est.ActualSurprise
EPS-0.180-0.090 0.0900
REV590.000K1.588M998.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ONCTOncternal Therapeutics2.02%274.5M

Oncternal Therapeutics Company Questions & Answers

Q

How do I buy Oncternal Therapeutics (ONCT) stock?

A

You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oncternal Therapeutics's (ONCT) main competitors?

A

Other companies in Oncternal Therapeutics’s space includes: Immunome (NASDAQ:IMNM), AVEO Pharmaceuticals (NASDAQ:AVEO) and Innate Pharma (NASDAQ:IPHA).

Q

What is the target price for Oncternal Therapeutics?

A

The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by Oppenheimer on 2021-04-07. The analyst firm set a price target for 14.00 expecting ONCT to rise to within 12 months (a possible 151.80% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Oncternal Therapeutics (ONCT) stock ?

A

The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $5.56 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Oncternal Therapeutics (ONCT) dividend?

A

There are no upcoming dividends for Oncternal Therapeutics.

Q

When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?

A
Oncternal Therapeutics’s Q2 earnings are confirmed after-market from now on August 5, 2021.
Q

When is the upcoming split for ONCT?

A

There is no upcoming split for Oncternal Therapeutics.